English

Shengtai Pharmaceutical, Inc.

EDGAR

SGTI Quarterly report (10-Q) · filed 2013-05-15

40 filing records in this dataset, filed from 2005-12-05 to 2013-05-15. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

49.7 million USD

2013 Q3 · USD

Exact inputs and evidence

Revenue: 49723426 USD Source

Operating margin

2.99%

2013 Q3 · %

Exact inputs and evidence

Operating Income: 1487345 USD Source
Revenue: 49723426 USD Source

Operating cash flow

-5.68 million USD

2013 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -4398469 USD Source
Operating Cash Flow: 1285014 USD Source

Free cash flow

-5.68 million USD

2013 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -4398469 USD Source
Operating Cash Flow: 1285014 USD Source
Capital Expenditure: 4276 USD Source
Capital Expenditure: 4259 USD Source

Cash and cash equivalents: 7.71 million USD 2013-03-31 Source
Exact value

7705512 USD
Long-term debt including current maturities: Not available
Shares outstanding: 9.58 million shares 2013-03-31 Source
Exact value

9584912 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

9584912 shares · 2012-03-31· Source
9584912 shares · 2013-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

219 million USD

2012-04-01 – 2013-03-31

Exact inputs and evidence

Revenue: 179029127 USD · 2011-07-01 – 2012-06-30 Source
Revenue: 122792481 USD · 2011-07-01 – 2012-03-31 Source
Revenue: 48744643 USD · 2012-07-01 – 2012-09-30 Source
Revenue: 64103621 USD · 2012-10-01 – 2012-12-31 Source
Revenue: 49723426 USD · 2013-01-01 – 2013-03-31 Source

Net income

719 thousand USD

2012-04-01 – 2013-03-31

Exact inputs and evidence

Net income: 1072594 USD · 2011-07-01 – 2012-06-30 Source
Net income: 916748 USD · 2011-07-01 – 2012-03-31 Source
Net income: 196301 USD · 2012-07-01 – 2012-09-30 Source
Net income: 261216 USD · 2012-10-01 – 2012-12-31 Source
Net income: 105218 USD · 2013-01-01 – 2013-03-31 Source

Operating cash flow

-17.7 million USD

2012-04-01 – 2013-03-31

Exact inputs and evidence

Operating cash flow: -23737700 USD · 2011-07-01 – 2012-06-30 Source
Operating cash flow: -10391666 USD · 2011-07-01 – 2012-03-31 Source
Operating cash flow: 4870243 USD · 2012-07-01 – 2012-09-30 Source
Operating cash flow: 1285014 USD · 2012-07-01 – 2012-12-31 Source
Operating cash flow: 4870243 USD · 2012-07-01 – 2012-09-30 Source
Operating cash flow: -4398469 USD · 2012-07-01 – 2013-03-31 Source
Operating cash flow: 1285014 USD · 2012-07-01 – 2012-12-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-05-15.

Financial data available through: 2012-06-30.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2012-06-30
Operating income: 2 of 11 periods available· newest 2012-06-30
Net income: 4 of 11 periods available· newest 2012-06-30
Operating cash flow: 4 of 11 periods available· newest 2012-06-30
Capital expenditure: 4 of 11 periods available· newest 2012-06-30
Total assets: 4 of 11 periods available· newest 2012-06-30
Total liabilities: 2 of 11 periods available· newest 2011-06-30
Current assets: 4 of 11 periods available· newest 2012-06-30
Current liabilities: 4 of 11 periods available· newest 2012-06-30
Cash and cash equivalents: 4 of 11 periods available· newest 2012-06-30
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2012-06-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+4.3%

Prior period

USD 171.72 million

2010-07-01 – 2011-06-30
Current period

USD 179.03 million

2011-07-01 – 2012-06-30

Exact inputs and evidence

179029127 − 171717866 = 7311261 USD

171717866 USD · 2010-07-01 – 2011-06-30
Inspect prior input Prior source
179029127 USD · 2011-07-01 – 2012-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Shengtai Pharmaceutical, Inc. · 2012-06-30 Shengtai Pharmaceutical, Inc. (edgar:1295079) Year-over-year change in Revenue: 7311261 USD Concept: fundies:Revenue Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 179029127 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#134430 Filing: 000114420412053501 Input fundies:Revenue: 171717866 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#133152 Filing: 000114420412053501
The citation records this snapshot. The page link may show a newer release later.
Net income
-86%

Prior period

USD 7.65 million

2010-07-01 – 2011-06-30
Current period

USD 1.07 million

2011-07-01 – 2012-06-30

Exact inputs and evidence

1072594 − 7651051 = -6578457 USD

7651051 USD · 2010-07-01 – 2011-06-30
Inspect prior input Prior source
1072594 USD · 2011-07-01 – 2012-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Shengtai Pharmaceutical, Inc. · 2012-06-30 Shengtai Pharmaceutical, Inc. (edgar:1295079) Year-over-year change in Net income: -6578457 USD Concept: fundies:NetIncome Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 1072594 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#143397 Filing: 000114420412053501 Input fundies:NetIncome: 7651051 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#142383 Filing: 000114420412053501
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-568.2%

Prior period

USD 5.07 million

2010-07-01 – 2011-06-30
Current period

−USD 23.74 million

2011-07-01 – 2012-06-30

Exact inputs and evidence

-23737700 − 5069599 = -28807299 USD

5069599 USD · 2010-07-01 – 2011-06-30
Inspect prior input Prior source
-23737700 USD · 2011-07-01 – 2012-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Shengtai Pharmaceutical, Inc. · 2012-06-30 Shengtai Pharmaceutical, Inc. (edgar:1295079) Year-over-year change in Operating cash flow: -28807299 USD Concept: fundies:OperatingCashFlow Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -23737700 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#154954 Filing: 000114420412053501 Input fundies:OperatingCashFlow: 5069599 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#154777 Filing: 000114420412053501
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-99.9%

Prior period

USD 2.02 million

2010-07-01 – 2011-06-30
Current period

USD 1,226

2011-07-01 – 2012-06-30

Exact inputs and evidence

1226 − 2018025 = -2016799 USD

2018025 USD · 2010-07-01 – 2011-06-30
Inspect prior input Prior source
1226 USD · 2011-07-01 – 2012-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Shengtai Pharmaceutical, Inc. · 2012-06-30 Shengtai Pharmaceutical, Inc. (edgar:1295079) Year-over-year change in Capital expenditure: -2016799 USD Concept: fundies:CapitalExpenditure Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1226 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#155656 Filing: 000114420412053501 Input fundies:CapitalExpenditure: 2018025 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#155479 Filing: 000114420412053501
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2012 2011-07-01 – 2012-06-30

Revenue USD 179.03 million 100% of revenue
Operating costs Derived USD 173.53 million 97% of revenue
Operating income USD 5.5 million 3.1% of revenue
Tax, interest and other Derived USD 4.43 million 2.5% of revenue
Net income USD 1.07 million 0.6% of revenue

Cash

Operating cash flow −USD 23.74 million −13% of revenue
Capital expenditure USD 1,226 0% of revenue
Free cash flow Derived −USD 23.74 million −13% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2004 Not shown: operating income or net income is not reported.
2005 Not shown: operating income or net income is not reported.
2011 92%
2012 97%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2004 2004-01-01 – 2004-12-31	0	Unavailable	Unavailable	Unavailable	-75564	-87714 Derived	Source 2004-01-01 – 2004-12-31: 0 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -75564 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -80684 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 7030 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	30318	Unavailable	Unavailable	Unavailable	-88966	-81365 Derived	Source 2005-01-01 – 2005-12-31: 30318 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -88966 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -81365 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 0 USD Inspect Capital Expenditure Open source
2011 2010-07-01 – 2011-06-30	171717866	158399090 Derived	13318776	5667725 Derived	7651051	3051574 Derived	Source 2010-07-01 – 2011-06-30: 171717866 USD Inspect Revenue Open source 2010-07-01 – 2011-06-30: 13318776 USD Inspect Operating Income Open source 2010-07-01 – 2011-06-30: 7651051 USD Inspect Net Income Open source 2010-07-01 – 2011-06-30: 5069599 USD Inspect Operating Cash Flow Open source 2010-07-01 – 2011-06-30: 2018025 USD Inspect Capital Expenditure Open source
2012 2011-07-01 – 2012-06-30	179029127	173530285 Derived	5498842	4426248 Derived	1072594	-23738926 Derived	Source 2011-07-01 – 2012-06-30: 179029127 USD Inspect Revenue Open source 2011-07-01 – 2012-06-30: 5498842 USD Inspect Operating Income Open source 2011-07-01 – 2012-06-30: 1072594 USD Inspect Net Income Open source 2011-07-01 – 2012-06-30: -23737700 USD Inspect Operating Cash Flow Open source 2011-07-01 – 2012-06-30: 1226 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 179M 2012

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Revenue	0	Revenue: 0 Open source
20052005-12-31	Revenue	30318	Revenue: 30318 Open source
20112011-06-30	Revenue	171717866	Revenue: 171717866 Open source
20122012-06-30	Revenue	179029127	Revenue: 179029127 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

4.3% 2012

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20052005-12-31	Year over year	No prior comparable period	Revenue: 30318 Open source Revenue: 0 Open source
20112011-06-30	Year over year	No prior comparable period	Revenue: 171717866 Open source
20122012-06-30	Year over year	4.3%	Revenue: 179029127 Open source Revenue: 171717866 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 3.1% 2012

Net margin 0.6% 2012

Free cash flow margin -13.3% 2012

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2004-12-31	Operating margin	Not reported	Revenue: 0 Open source
2005-12-31	Operating margin	Not reported	Revenue: 30318 Open source
20112011-06-30	Operating margin	7.8%	Operating Income: 13318776 Open source Revenue: 171717866 Open source
20122012-06-30	Operating margin	3.1%	Operating Income: 5498842 Open source Revenue: 179029127 Open source
20042004-12-31	Net margin	Not reported	Net Income: -75564 Open source Revenue: 0 Open source
20052005-12-31	Net margin	-293.4%	Net Income: -88966 Open source Revenue: 30318 Open source
20112011-06-30	Net margin	4.5%	Net Income: 7651051 Open source Revenue: 171717866 Open source
20122012-06-30	Net margin	0.6%	Net Income: 1072594 Open source Revenue: 179029127 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -80684 Open source Capital Expenditure: 7030 Open source
20052005-12-31	Free cash flow margin	-268.4%	Revenue: 30318 Open source Operating Cash Flow: -81365 Open source Capital Expenditure: 0 Open source
20112011-06-30	Free cash flow margin	1.8%	Revenue: 171717866 Open source Operating Cash Flow: 5069599 Open source Capital Expenditure: 2018025 Open source
20122012-06-30	Free cash flow margin	-13.3%	Revenue: 179029127 Open source Operating Cash Flow: -23737700 Open source Capital Expenditure: 1226 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -23.7M 2012

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Operating cash flow	-80684	Operating Cash Flow: -80684 Open source
20052005-12-31	Operating cash flow	-81365	Operating Cash Flow: -81365 Open source
20112011-06-30	Operating cash flow	5069599	Operating Cash Flow: 5069599 Open source
20122012-06-30	Operating cash flow	-23737700	Operating Cash Flow: -23737700 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -23.7M 2012

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Free cash flow	-87714	Operating Cash Flow: -80684 Open source Capital Expenditure: 7030 Open source
20052005-12-31	Free cash flow	-81365	Operating Cash Flow: -81365 Open source Capital Expenditure: 0 Open source
20112011-06-30	Free cash flow	3051574	Operating Cash Flow: 5069599 Open source Capital Expenditure: 2018025 Open source
20122012-06-30	Free cash flow	-23738926	Operating Cash Flow: -23737700 Open source Capital Expenditure: 1226 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

58.7% 2011

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2004-12-31	Liabilities / assets	Not reported	Total Assets: 31400 Open source
20052005-12-31	Liabilities / assets	495%	Total Liabilities: 72139 Open source Total Assets: 14573 Open source
20112011-06-30	Liabilities / assets	58.7%	Total Liabilities: 84617050 Open source Total Assets: 144239174 Open source
2012-06-30	Liabilities / assets	Not reported	Total Assets: 172585052 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.67× 2012

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Current assets / current liabilities	Not reported	Current Assets: 16800 Open source Current Liabilities: 0 Open source
20052005-12-31	Current assets / current liabilities	0.15×	Current Assets: 11105 Open source Current Liabilities: 72139 Open source
20112011-06-30	Current assets / current liabilities	0.57×	Current Assets: 48093131 Open source Current Liabilities: 84617050 Open source
20122012-06-30	Current assets / current liabilities	0.67×	Current Assets: 74022195 Open source Current Liabilities: 110250526 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2004 2004-01-01 – 2004-12-31	−USD 75,564 Exact value Exact value: -75564 USD 2004-01-01 – 2004-12-31: -75564 USD Inspect Net Income Open source Share or cite Citation for Net Income · Shengtai Pharmaceutical, Inc. · 2004-12-31 Shengtai Pharmaceutical, Inc. (edgar:1295079) Net Income: -75564 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -75564 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/0001323914-06-000025.txt#1144 The citation records this snapshot. The page link may show a newer release later.	−USD 80,684 Exact value Exact value: -80684 USD 2004-01-01 – 2004-12-31: -80684 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Shengtai Pharmaceutical, Inc. · 2004-12-31 Shengtai Pharmaceutical, Inc. (edgar:1295079) Operating Cash Flow: -80684 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -80684 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/0001323914-06-000025.txt#1154 The citation records this snapshot. The page link may show a newer release later.	USD 7,030 Exact value Exact value: 7030 USD 2004-01-01 – 2004-12-31: 7030 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Shengtai Pharmaceutical, Inc. · 2004-12-31 Shengtai Pharmaceutical, Inc. (edgar:1295079) Capital Expenditure: 7030 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7030 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/0001323914-06-000025.txt#1157 The citation records this snapshot. The page link may show a newer release later.	−USD 87,714 Calculation and evidence -80684 − 7030 USD Exact free cash flow: -87714 USD 2004-01-01 – 2004-12-31: -80684 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 7030 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Shengtai Pharmaceutical, Inc. · 2004-12-31 Shengtai Pharmaceutical, Inc. (edgar:1295079) Free cash flow: -87714 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -80684 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/0001323914-06-000025.txt#1154 Input fundies:CapitalExpenditure: 7030 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/0001323914-06-000025.txt#1157 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 88,966 Exact value Exact value: -88966 USD 2005-01-01 – 2005-12-31: -88966 USD Inspect Net Income Open source Share or cite Citation for Net Income · Shengtai Pharmaceutical, Inc. · 2005-12-31 Shengtai Pharmaceutical, Inc. (edgar:1295079) Net Income: -88966 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -88966 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/0001323914-06-000025.txt#1144 The citation records this snapshot. The page link may show a newer release later.	−USD 81,365 Exact value Exact value: -81365 USD 2005-01-01 – 2005-12-31: -81365 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Shengtai Pharmaceutical, Inc. · 2005-12-31 Shengtai Pharmaceutical, Inc. (edgar:1295079) Operating Cash Flow: -81365 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -81365 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/0001323914-06-000025.txt#1154 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2005-01-01 – 2005-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Shengtai Pharmaceutical, Inc. · 2005-12-31 Shengtai Pharmaceutical, Inc. (edgar:1295079) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/0001323914-06-000025.txt#1157 The citation records this snapshot. The page link may show a newer release later.	−USD 81,365 Calculation and evidence -81365 − 0 USD Exact free cash flow: -81365 USD 2005-01-01 – 2005-12-31: -81365 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Shengtai Pharmaceutical, Inc. · 2005-12-31 Shengtai Pharmaceutical, Inc. (edgar:1295079) Free cash flow: -81365 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -81365 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/0001323914-06-000025.txt#1154 Input fundies:CapitalExpenditure: 0 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/0001323914-06-000025.txt#1157 The citation records this snapshot. The page link may show a newer release later.
2011 2010-07-01 – 2011-06-30	USD 7.65 million Exact value Exact value: 7651051 USD 2010-07-01 – 2011-06-30: 7651051 USD Inspect Net Income Open source Share or cite Citation for Net Income · Shengtai Pharmaceutical, Inc. · 2011-06-30 Shengtai Pharmaceutical, Inc. (edgar:1295079) Net Income: 7651051 USD Concept: fundies:NetIncome Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079/explain?concept=fundies%3ANetIncome&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:NetIncome: 7651051 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#142383 Filing: 000114420412053501 The citation records this snapshot. The page link may show a newer release later.	USD 5.07 million Exact value Exact value: 5069599 USD 2010-07-01 – 2011-06-30: 5069599 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Shengtai Pharmaceutical, Inc. · 2011-06-30 Shengtai Pharmaceutical, Inc. (edgar:1295079) Operating Cash Flow: 5069599 USD Concept: fundies:OperatingCashFlow Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079/explain?concept=fundies%3AOperatingCashFlow&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5069599 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#154777 Filing: 000114420412053501 The citation records this snapshot. The page link may show a newer release later.	USD 2.02 million Exact value Exact value: 2018025 USD 2010-07-01 – 2011-06-30: 2018025 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Shengtai Pharmaceutical, Inc. · 2011-06-30 Shengtai Pharmaceutical, Inc. (edgar:1295079) Capital Expenditure: 2018025 USD Concept: fundies:CapitalExpenditure Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079/explain?concept=fundies%3ACapitalExpenditure&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2018025 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#155479 Filing: 000114420412053501 The citation records this snapshot. The page link may show a newer release later.	USD 3.05 million Calculation and evidence 5069599 − 2018025 USD Exact free cash flow: 3051574 USD 2010-07-01 – 2011-06-30: 5069599 USD · Inspect Operating Cash Flow · Source 2010-07-01 – 2011-06-30: 2018025 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Shengtai Pharmaceutical, Inc. · 2011-06-30 Shengtai Pharmaceutical, Inc. (edgar:1295079) Free cash flow: 3051574 USD Concept: free-cash-flow Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5069599 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#154777 Filing: 000114420412053501 Input fundies:CapitalExpenditure: 2018025 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#155479 Filing: 000114420412053501 The citation records this snapshot. The page link may show a newer release later.
2012 2011-07-01 – 2012-06-30	USD 1.07 million Exact value Exact value: 1072594 USD 2011-07-01 – 2012-06-30: 1072594 USD Inspect Net Income Open source Share or cite Citation for Net Income · Shengtai Pharmaceutical, Inc. · 2012-06-30 Shengtai Pharmaceutical, Inc. (edgar:1295079) Net Income: 1072594 USD Concept: fundies:NetIncome Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079/explain?concept=fundies%3ANetIncome&period=2012-06-30&surface=latest&period_type=duration&start=2011-07-01&unit=USD&dimensions= Input fundies:NetIncome: 1072594 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#143397 Filing: 000114420412053501 The citation records this snapshot. The page link may show a newer release later.	−USD 23.74 million Exact value Exact value: -23737700 USD 2011-07-01 – 2012-06-30: -23737700 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Shengtai Pharmaceutical, Inc. · 2012-06-30 Shengtai Pharmaceutical, Inc. (edgar:1295079) Operating Cash Flow: -23737700 USD Concept: fundies:OperatingCashFlow Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079/explain?concept=fundies%3AOperatingCashFlow&period=2012-06-30&surface=latest&period_type=duration&start=2011-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23737700 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#154954 Filing: 000114420412053501 The citation records this snapshot. The page link may show a newer release later.	USD 1,226 Exact value Exact value: 1226 USD 2011-07-01 – 2012-06-30: 1226 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Shengtai Pharmaceutical, Inc. · 2012-06-30 Shengtai Pharmaceutical, Inc. (edgar:1295079) Capital Expenditure: 1226 USD Concept: fundies:CapitalExpenditure Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079/explain?concept=fundies%3ACapitalExpenditure&period=2012-06-30&surface=latest&period_type=duration&start=2011-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1226 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#155656 Filing: 000114420412053501 The citation records this snapshot. The page link may show a newer release later.	−USD 23.74 million Calculation and evidence -23737700 − 1226 USD Exact free cash flow: -23738926 USD 2011-07-01 – 2012-06-30: -23737700 USD · Inspect Operating Cash Flow · Source 2011-07-01 – 2012-06-30: 1226 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Shengtai Pharmaceutical, Inc. · 2012-06-30 Shengtai Pharmaceutical, Inc. (edgar:1295079) Free cash flow: -23738926 USD Concept: free-cash-flow Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T19:28:36Z Snapshot: 44d4e29b555f3abbbacc0afab0e7644c5e53bfa14579666004c618ebd436de12 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1295079?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23737700 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#154954 Filing: 000114420412053501 Input fundies:CapitalExpenditure: 1226 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1295079/000114420412053501/sgti-20120630.xml#155656 Filing: 000114420412053501 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

40 filings · 657 latest values · 657 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001295079, 1295079, SGTI, edgar:1295079, sgti

Also known as SHENGTAI PHARMACEUTICAL, INC., Shengtai Pharmaceutical, Inc., West Coast Car CO

Shengtai Pharmaceutical, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2012 2011-07-01 – 2012-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation